IFNG and neoplasm: As shown in Figure 7A, the HY-oAd+9-ING-41 combination group showed a significantly higher number of IFN-γ-secreting lymphocytes over the respective monotherapy (*p < 0.05, **p < 0.01), suggesting that it could induce a potent tumor-specific adaptive immune response.